Clinical trialNCT04410354TerminatedPhase 2Interventional

Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19

SponsorViralClear Pharmaceuticals, Inc.Enrollment44COVID-19

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to assess the safety and efficacy of merimepodib (MMPD) oral solution when administered in combination with remdesivir in adult patients with advanced COVID-19.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Andrew Badley, MD
Mayo Clinic
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Mayo Clinic in Arizona
Phoenix, Arizona, United States
Holy Cross Hospital
Fort Lauderdale, Florida, United States
Mayo Clinic in Florida
Jacksonville, Florida, United States
Mayo Clinic
Rochester, Minnesota, United States
Atlantic Health System / Morristown Medical Center
Morristown, New Jersey, United States
Atlantic Health System / Overlook Medical Center
Summit, New Jersey, United States
St. David'S Medical Center
Austin, Texas, United States
St. David'S South Austin Medical Center
Austin, Texas, United States
Hca Houston Healthcare Medical Center
Houston, Texas, United States
Hca Houston Healthcare Mainland
Texas City, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Matching PlaceboMerimepodibRemdesivir →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 16 Jun 2020
Primary completion: 1 Dec 2020
Completion: 1 Dec 2020
Last update posted: 8 Dec 2020
Registered enrollment: 44
Registry id: NCT04410354

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.